E

Esperion Therapeutics

389 employees

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Small Molecule
Health Care
Cardiovascular
LDL-C
Medical
Research & Development
Pharmaceutical
Late-state Pharmaceutical Company
Statin

Date founded

2008

Funding rounds raised

Total raised

$50M

from 9 investors over 9 rounds

E

Esperion Therapeutics raised $50M on April 26, 2021

Investors: Oberland Capital

E

Esperion Therapeutics raised $33M on April 25, 2013

Investors: Aisling Capital, Domain Associates, Longitude Capital, Alta Partners and Asset Management Ventures

E

Esperion Therapeutics raised $23M on May 1, 2008

Investors: Aisling Capital, Alta Partners and Domain Associates

FAQ